Medication info

Zantac Tablet (Ranitidine Hydrochloride)

Prescription medicationTabletOralExpired
Ingredient · strength
Ranitidine Hydrochloride›168mg / 1 tablet
Manufacturer / importer
Sears Pharmaceuticals, Co., Ltd.
Appearance
Pale yellow to yellow round film-coated tablets
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Expired

MFDS item code 201805028 · Approved 2018.12.11

This product's status changed to Expired on 2023.12.11. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Treatment of acid-related disorders (gastric ulcers, etc.), improvement of gastric mucosal lesions, and prevention of Mendelson's syndrome
Who takes it
Adults · Children
Adult dose
Administer 150 mg orally twice daily, in the morning and at bedtime. 1) Gastric and duodenal ulcers Administer 150 mg of this medicine orally twice daily, or 300 mg once daily at bedtime. A higher healing rate may be achieved, particularly in patients with duodenal ulcers, by administering 300 mg twice daily, in the morning and at bedtime. The dosage is the same when used concomitantly to treat ulcers caused by nonsteroidal anti-inflammatory drugs or to prevent gastric and duodenal ulcers during long-term use of nonsteroidal anti-inflammatory drugs. Healing generally occurs within 4 weeks; conditions caused by nonsteroidal anti-inflammatory drugs generally heal within 8 weeks, although healing may take longer in some patients. For patients with recurrent ulcers who responded well to short-term treatment with this medicine, administer 150 mg once daily at bedtime as maintenance therapy. 2) Reflux esophagitis Administer 150 mg of this medicine twice daily for 8 weeks, or 300 mg once daily at bedtime. For patients with severe reflux esophagitis, the dose may be increased to 150 mg 4 times daily. 3) Zollinger-Ellison syndrome Start treatment with an initial dose of 150 mg of this medicine 3 times daily, and increase the dose as needed. In severe cases, up to 6 g daily may be administered as directed by a physician. 4) For upper gastrointestinal bleeding caused by peptic ulcers, acute stress ulcers, or acute gastric mucosal lesions, treatment is generally initiated with an injection. Once oral administration is possible, switch to oral administration and give 150 mg of this medicine twice daily. 5) Premedication before anesthesia (prevention of Mendelson's syndrome) Administer 150 mg of this medicine 2 hours before induction of anesthesia. It is preferable to also administer 150 mg on the night before surgery. 6) Improvement of gastric mucosal lesions (erosion, bleeding, erythema, edema) in the following conditions: acute gastritis and acute exacerbation of chronic gastritis Administer 150 mg of this medicine once daily at bedtime. 7) Hyperacidity, heartburn, acid regurgitation: 3. Patients with renal impairment For patients with severe renal impairment and creatinine clearance of 50 mL/min or less, administer 150 mg once daily at bedtime. Depending on the patient's condition, the dosing interval may be extended to 12 hours or longer. Hemodialysis decreases the blood concentration of the drug; therefore, adjust the dosing schedule immediately after hemodialysis. Adjust the dose as appropriate according to age and symptoms.
Child dose
For patients aged 12 years and older, administer 75 mg of this medicine orally twice daily (oral solution only). For patients aged 8 〜 18 years, up to 150 mg per dose (2 mg per kg of body weight) may be administered twice daily.

Ingredients

Manufacturer
Sears Pharmaceuticals, Co., Ltd.

Efficacy & effects

Treatment of acid-related disorders (gastric ulcers, etc.), improvement of gastric mucosal lesions, and prevention of Mendelson's syndrome

  • Gastric and duodenal ulcers
  • Zollinger-Ellison syndrome
  • gastroesophageal reflux disease
  • prevention of Mendelson's syndrome
  • postoperative ulcers
  • gastric and duodenal ulcers caused by the use of non-steroidal anti-inflammatory drugs (NSAIDs)
  • gastric mucosal lesions
  • erosion
  • bleeding
  • redness
  • swelling
  • acute gastritis
View approved original text

This medication is used to treat ulcers in the stomach and duodenum, Zollinger-Ellison syndrome, and gastroesophageal reflux disease. It is also effective for preoperative dosing to prevent Mendelson's syndrome and for the treatment of ulcers due to the use of non-steroidal anti-inflammatory drugs (NSAIDs). It improves acute exacerbations of acute and chronic gastric inflammation and gastric mucosal lesions such as upper gastrointestinal bleeding, and helps alleviate symptoms of heartburn and acid regurgitation caused by excessive gastric acid. It effectively improves symptoms of various gastrointestinal diseases.

How to take

Adult dose

Administer 150 mg orally twice daily, in the morning and at bedtime. 1) Gastric and duodenal ulcers Administer 150 mg of this medicine orally twice daily, or 300 mg once daily at bedtime. A higher healing rate may be achieved, particularly in patients with duodenal ulcers, by administering 300 mg twice daily, in the morning and at bedtime. The dosage is the same when used concomitantly to treat ulcers caused by nonsteroidal anti-inflammatory drugs or to prevent gastric and duodenal ulcers during long-term use of nonsteroidal anti-inflammatory drugs. Healing generally occurs within 4 weeks; conditions caused by nonsteroidal anti-inflammatory drugs generally heal within 8 weeks, although healing may take longer in some patients. For patients with recurrent ulcers who responded well to short-term treatment with this medicine, administer 150 mg once daily at bedtime as maintenance therapy. 2) Reflux esophagitis Administer 150 mg of this medicine twice daily for 8 weeks, or 300 mg once daily at bedtime. For patients with severe reflux esophagitis, the dose may be increased to 150 mg 4 times daily. 3) Zollinger-Ellison syndrome Start treatment with an initial dose of 150 mg of this medicine 3 times daily, and increase the dose as needed. In severe cases, up to 6 g daily may be administered as directed by a physician. 4) For upper gastrointestinal bleeding caused by peptic ulcers, acute stress ulcers, or acute gastric mucosal lesions, treatment is generally initiated with an injection. Once oral administration is possible, switch to oral administration and give 150 mg of this medicine twice daily. 5) Premedication before anesthesia (prevention of Mendelson's syndrome) Administer 150 mg of this medicine 2 hours before induction of anesthesia. It is preferable to also administer 150 mg on the night before surgery. 6) Improvement of gastric mucosal lesions (erosion, bleeding, erythema, edema) in the following conditions: acute gastritis and acute exacerbation of chronic gastritis Administer 150 mg of this medicine once daily at bedtime. 7) Hyperacidity, heartburn, acid regurgitation: 3. Patients with renal impairment For patients with severe renal impairment and creatinine clearance of 50 mL/min or less, administer 150 mg once daily at bedtime. Depending on the patient's condition, the dosing interval may be extended to 12 hours or longer. Hemodialysis decreases the blood concentration of the drug; therefore, adjust the dosing schedule immediately after hemodialysis. Adjust the dose as appropriate according to age and symptoms.

Child dose

For patients aged 12 years and older, administer 75 mg of this medicine orally twice daily (oral solution only). For patients aged 8 〜 18 years, up to 150 mg per dose (2 mg per kg of body weight) may be administered twice daily.

Precautions

This medication should not be used in patients who have had an allergic reaction to this drug or its components. Avoid administration in patients with a history of acute porphyria, as this drug may precipitate seizures. Patients with impaired kidney function may have increased blood concentration due to renal excretion, requiring dose adjustments. Patients with liver dysfunction should also use this medication with caution. Patients with a history of drug allergy or elderly patients should administer this drug carefully. When combined with non-steroidal anti-inflammatory drugs, especially in the elderly or those with a history of peptic ulcers, regular monitoring of the condition is necessary. This medication may mask symptoms of gastric cancer, so it should be confirmed that it is not cancer if symptoms of gastric ulcer or dyspepsia arise or change in middle-aged patients or older. Patients with gastric and duodenal ulcers with Helicobacter pylori infection should undergo bacterial eradication therapy. Rarely, this medication can cause severe allergic reactions or anaphylactic shock, so if any unusual symptoms occur during administration, treatment should be discontinued immediately. If skin rashes, hives, or bronchospasm occur, use should be discontinued. Various side effects, including blood-related symptoms, liver dysfunction, cardiac arrhythmias, gastrointestinal symptoms, and neurological symptoms may rarely occur, so any unusual symptoms should be reported immediately. Patients with poor kidney function should particularly be cautious of symptoms such as mental confusion or seizures. This medication should be used at the minimum dose while confirming the therapeutic effect, and if ineffective, other treatments should be considered. Elderly patients and those with chronic lung disease, diabetes, or weakened immune systems may have an increased risk of pneumonia, which should be monitored carefully. Avoid driving or operating dangerous machinery if dizziness or drowsiness occurs. This medication may interact with other drugs, so inform your doctor or pharmacist about any concurrent medications. In particular, cautiously observe for bleeding risks when used with warfarin. Women who are pregnant or may become pregnant, as well as nursing mothers, should carefully consider the risks and benefits if this medication is necessary. Safety in pediatric patients has not been sufficiently established, so caution is needed when using. Elderly patients may require dose adjustments due to increased drug concentration from decreased kidney function. Overdose is rarely accompanied by specific toxic symptoms, but gastric lavage or symptomatic treatment should be provided if necessary. Keep out of reach of children and do not transfer to other containers.

Side effects

  • Anaphylactic shock
  • urticaria
  • angioedema
  • rash
  • fever
  • bronchospasm
  • hypotension
  • chest pain
  • granulocytopenia
  • elevated serum creatinine levels
Show 52 more
  • leukopenia
  • thrombocytopenia
  • aplastic anemia
  • myelofibrosis
  • refractory anemia
  • agranulocytosis
  • pancytopenia
  • acquired immune hemolytic anemia
  • eosinophilia
  • liver dysfunction
  • jaundice
  • hepatitis
  • bradycardia
  • heart block
  • tachycardia
  • vasculitis
  • constipation
  • nausea
  • vomiting
  • abdominal distension
  • abdominal pain
  • loss of appetite
  • diarrhea
  • acute pancreatitis
  • dizziness
  • drowsiness
  • seizures
  • headache
  • heaviness
  • insomnia
  • agitation
  • anxiety
  • mental confusion
  • depression
  • hallucination
  • blurred vision
  • involuntary movements
  • altered consciousness
  • tonic cramps
  • gynecomastia
  • galactorrhea
  • erectile dysfunction
  • decreased libido
  • arthralgia
  • myalgia
  • rhabdomyolysis
  • skin rash
  • erythema multiforme
  • alopecia
  • stomatitis
  • pruritus
  • acute interstitial nephritis

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container that protects from light, at a temperature between 1 to 30 degrees Celsius. Storing it this way will help safely maintain the effectiveness of the medication.

Appearance and packaging

Appearance

Pale yellow to yellow round film-coated tablets

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.